Cornyn Calls for Examination of Patent Process for Prescription Drugs


In: All News   Posted 02/26/2019
Share:

Senator Cornyn questions AbbVie CEO during Finance Committee hearing

WASHINGTON – During a Senate Finance Committee hearing on drug pricing, U.S. Senator John Cornyn (R-TX) today questioned AbbVie CEO Rick Gonzalez on the company’s use of patents to protect their prescription drugs. Excerpts of Sen. Cornyn’s line of questioning are below, and video can be found here.

SENATOR JOHN CORNYN: “We want to make sure that we maintain the most innovative pharmaceutical drug companies in the world because we want to provide life-saving cures for our people, and I get the idea that that’s the purpose of the patent system, which is to protect the exclusivity of that drug that you’ve sunk a lot of money into the research and development for.”

SEN. CORNYN: “But at some point, that patent has to end, that exclusivity has to end, so that the patients can get access to those drugs at a much cheaper cost.”

SEN. CORNYN: “I think this is an area that we need to look into through our Judiciary Committee authority as well.”